EC Number   |
Specific Activity Minimum [µmol/min/mg] |
Specific Activity Maximum [µmol/min/mg] |
Reference |
|---|
   3.1.6.2 | -999 |
- |
- |
645797, 654540, 656641, 656646 |
| 3.1.6.2 | -999 |
- |
higher specific activity in the dermal papilla by a factor of 6-8 than in the connective tissue sheaths or root sheaths |
656443 |
| 3.1.6.2 | -999 |
- |
no sex- or age-specific differences in cerebral STS activity |
656590 |
| 3.1.6.2 | -999 |
- |
STS activities in male or female aortas with different degrees of atherosclerotic changes |
645740 |
| 3.1.6.2 | -999 |
- |
STS activity in 86% of human endometrial cancer tissue, 26% in normal endometrial tissue in 26%, confirmed by immunohistochemistry, STS acitivity in MCF-7 breast cancer cells about 20 fmol/20 h/million cells, STS acitivity in Ishikawa endometrial cancer cells 39.4 fmol/20 h/million cells, STS acitivity in LNCaP prostate cancer cells 41.5 fmol/20 h/million cells, STS acitivity in OVCAR-3 ovarian cancer cells 127.4 fmol/20 h/million cells |
690441 |
| 3.1.6.2 | 0.000002961 |
- |
- |
656637 |
| 3.1.6.2 | 0.0000128 |
- |
pH 7.5, 37°C, subcortical white matter |
656590 |
| 3.1.6.2 | 0.000015 |
- |
in primary mammary carcinoma |
135612 |
| 3.1.6.2 | 0.0000265 |
- |
pH 7.5, 37°C, cerebral neocortex |
656590 |
| 3.1.6.2 | 0.385 |
- |
pH 6.4, 37°C |
656643 |
